FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “delivery process”

Showing 1 - 10 of 119

Image-Content

OPINION

Let the capable lead

News, Editorial, Published on 16/09/2024

» The recent scandal involving an alleged audio clip of former deputy prime minister and Palang Pracharath Party leader Gen Prawit Wongsuwon talking about promotions has reignited concerns about Thailand's deep-rooted patronage system in civil service appointments.

OPINION

Rambling Joe Biden officially a lost cause

Oped, Gwynne Dyer, Published on 13/07/2024

» It really doesn't matter whether Joe Biden is in peak condition intellectually during a second term as president. He did some useful things in his first term, but his main job now is to stop Donald Trump from coming back. If he succeeded in doing that and went gaga immediately afterwards, the ship of state would carry on regardless.

Image-Content

OPINION

Some US doctors don't understand menopause

News, Published on 13/05/2024

» A new analysis of a controversial study affirms something menopause experts have long argued: For many women, the benefits of short-term hormone replacement therapy (HRT) outweigh their risks.

Image-Content

OPINION

Time for Myanmar aid, trade rethink?

Oped, Published on 11/05/2024

» The Myanmar military's recent defeats in and around the border town of Myawaddy at the hands of the Karen National Liberation Army (KNLA) and pro-democracy resistance forces should serve as a wake-up call for Thailand.

Image-Content

OPINION

Lifting Asean's efforts with Myanmar

Oped, Published on 27/04/2024

» About three years ago, Asean leaders gathered in Jakarta for an emergency summit on Myanmar at which the Five-Point Consensus (5PC) -- entailing the cessation of violence in the country, constructive dialogue among parties to the conflict, the appointment of a special Myanmar envoy and the provision of humanitarian assistance -- was agreed upon with the State Administration Council's (SAC) senior general Min Aung Hlaing.

OPINION

Ensuring safety and health at work

Oped, Published on 26/04/2024

» Climate change is having serious impacts on the safety and health of workers in the Asia-Pacific region.

Image-Content

OPINION

Teaching firms about public health

Oped, Published on 21/02/2024

» Corporations are increasingly moving into the public health domain. Companies like Amazon, Google, and Microsoft are being "pulled" by market opportunities for non-traditional actors to "disrupt" health care. Others are being "pushed" by the imperative -- highlighted by events like the Covid-19 pandemic -- to act as responsible community stakeholders, such as by helping to address health inequities.

Image-Content

OPINION

Lao Asean chair: better comfort level

Oped, Kavi Chongkittavorn, Published on 06/02/2024

» The outgrowth of the latest Asean foreign ministers' retreat in Luang Prabang last week palpably shows a better comfort level between the host and their colleagues. Such a casual atmosphere generated better outcomes without politicising or dragging on contentious issues. Most importantly, Vientiane's diplomatic finesse is highly visible in its third chairmanship in approaching Asean-related issues and challenges: the thinking is less is more with clear-cut priorities. If this trajectory continues, the Lao chair will be lauded.

Image-Content

OPINION

How to get more from Thai teachers

Oped, Published on 27/12/2023

» There are many shortcomings in the Thai education system; however, for improvements, a good place to start might be with the teachers.

Image-Content

OPINION

A bargain in saving lives from malaria

News, Peter Singer, Published on 21/12/2023

» In 2021, malaria caused 619,000 deaths, 77% of which were children under five, and 96% of them in Africa. But now, after decades of research -- and several false dawns -- a malaria vaccine known as R21/Matrix-M (henceforth just R21) has been shown to be effective in 70-78% of cases. Although three doses are required before that level of protection is reached, and a booster is needed one year later, the vaccine, developed at the University of Oxford and the Serum Institute of India, is cheap. It can be produced for US$2-$4 (70-140 baht) per dose -- comparable to the cost of other childhood vaccines.